Tezcan Gecgil

Tezcan Gecgil

Expertise: ETFs, Options Trading, Technical and Fundamental Analysis

Education: PhD (Business Studies), MSc (Investment Banking & Trading), MBA

Awards & Accomplishments: Completed all 3 levels of the Chartered Market Technician (CMT) qualification

About Tezcan
Tezcan Gecgil, PhD, began contributing to InvestorPlace in 2018. She has worked in investment management in the U.S. and U.K., including a Greenwich, Connecticut-based hedge fund as well as the American Stock Exchange, CFA Institute, and Bloomberg. She has also taught at various U.S. and U.K. universities.

She holds Ph.D. (Business Studies) as well as MSc (Investment Banking & Trading) and MBA degrees from leading U.S. and U.K. universities and has also completed all three levels of the Chartered Market Technician (CMT) examination.

Her passion is for options trading based on technical analysis of fundamentally strong companies. She especially enjoys setting up weekly covered calls for income generation. Publicly, she has also contributed to investing.com and the U.K. website of The Motley Fool. She is also part of the investment management writing team at Copylab.

When not navigating the markets, Tezcan delves into the mysteries of history and explores new destinations.

Recent Articles

Nikola Stock Is Likely to See $35 Before $70

As the Nikola stock float increases, NKLA shares are likely to fall below $40. If you currently have paper profits, you may want to cash in

New NASCAR Event May Speed DVD Stock to Greater Profits

DVD stock trades for less than $2 per share, but a new four-year deal to host NASCAR races in Nashville to put DVD in the winner's circle.

XpresSpa Doesn’t Look Any Better After Its Reverse Split

Unless airport passenger numbers show consistent growth and revenue levels improve, XSPA stock cannot create shareholder value.

4 California Stocks to Keep On Hold Until Post-Coronavirus

These four strong California stocks deserve your attention and further due diligence to be included in long-term portfolios.

Royalty Pharma Stock Is Likely to Reach New Highs in the Coming Years

Recent IPO by Royalty Pharma which acquires ownership interests in drug royalties is getting a lot of interest on Wall Street. Long-term investors may want to keep a close eye on RPRX stock

Avoid Wells Fargo Stock Before Its Earnings Report

As earnings season kicks in, Wells Fargo stock is likely to be volatile with a downward bias. Investors should avoid WFC for now.

Xerox Stock Is Likely To Go Below $15 and Stay There Through July

Xerox stock is likely to suffer in July especially if Q2 results show that the pandemic has meant further downward sales trajectory for the printer-and-copier company

3 Furniture Stocks Making Work-From-Home More Comfortable

The second part of 2020 will likely see growth in these three furniture stocks that are making work-from-home more comfortable.

Grab Nvidia Shares If the Stock Dips to $300 at Earnings

Long-term investors may regard any potential pullback in NVDA stock in July as opportunity to buy the shares.

3 Penny Stocks That Are Poised for Big Gains

Each of these penny stocks holds significant long-term promise, along with some undeniable risk too. Here's what you need should know about each company.